| Dr Jennifer Ann Mittlestead, MD | |
|
5701 Far Hills Ave, Dayton, OH 45429-2207 | |
| (937) 435-6222 | |
| Not Available |
| Full Name | Dr Jennifer Ann Mittlestead |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 13 Years |
| Location | 5701 Far Hills Ave, Dayton, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295024131 | NPI | - | NPPES |
| 2147224 | Other | OH | GROUP MEDICAID |
| 9271701 | Other | OH | GROUP MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0000X | Obstetrics & Gynecology - Obstetrics | 35.125512 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Far Hills Ob Gyn Inc | 5395773998 | 7 |
News Archive
RegeneRx Biopharmaceuticals, Inc. announced today that in a preclinical research paper published in the May 2010 issue of the Journal of Neurosurgery, (online ahead of publication), scientists found that the systemic administration of thymosin beta 4, or Tβ4, significantly reduced brain tissue damage and improved brain function in rats with traumatic brain injury, or TBI.
Results of the MR WITNESS study suggest that magnetic resonance imaging may be able to identify patients with strokes that can be treated with tissue plasminogen activator, even if the time of symptom onset is unknown.
GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.
On July 9 Prime Minister of the Russian Federation Dmitry Medvedev, presented Russia's first national "Industry" award to a biopharmaceutical company BIOCAD.
› Verified 5 days ago
| Entity Name | Far Hills Ob Gyn Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962602680 PECOS PAC ID: 5395773998 Enrollment ID: O20050803000533 |
News Archive
RegeneRx Biopharmaceuticals, Inc. announced today that in a preclinical research paper published in the May 2010 issue of the Journal of Neurosurgery, (online ahead of publication), scientists found that the systemic administration of thymosin beta 4, or Tβ4, significantly reduced brain tissue damage and improved brain function in rats with traumatic brain injury, or TBI.
Results of the MR WITNESS study suggest that magnetic resonance imaging may be able to identify patients with strokes that can be treated with tissue plasminogen activator, even if the time of symptom onset is unknown.
GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.
On July 9 Prime Minister of the Russian Federation Dmitry Medvedev, presented Russia's first national "Industry" award to a biopharmaceutical company BIOCAD.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jennifer Ann Mittlestead, MD 5701 Far Hills Ave, Dayton, OH 45429-2207 Ph: (937) 435-6222 | Dr Jennifer Ann Mittlestead, MD 5701 Far Hills Ave, Dayton, OH 45429-2207 Ph: (937) 435-6222 |
News Archive
RegeneRx Biopharmaceuticals, Inc. announced today that in a preclinical research paper published in the May 2010 issue of the Journal of Neurosurgery, (online ahead of publication), scientists found that the systemic administration of thymosin beta 4, or Tβ4, significantly reduced brain tissue damage and improved brain function in rats with traumatic brain injury, or TBI.
Results of the MR WITNESS study suggest that magnetic resonance imaging may be able to identify patients with strokes that can be treated with tissue plasminogen activator, even if the time of symptom onset is unknown.
GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.
On July 9 Prime Minister of the Russian Federation Dmitry Medvedev, presented Russia's first national "Industry" award to a biopharmaceutical company BIOCAD.
› Verified 5 days ago
Dr. Susan M Emmerling, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 9000 N Main St, Suite 232, Dayton, OH 45415 Phone: 937-277-8988 Fax: 937-274-4293 | |
Jiri David Sonek, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Wyoming St, Berry Bldg, Ground Fl, Dayton, OH 45409 Phone: 937-208-2516 Fax: 937-208-6124 | |
Nancy G Romer, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1 Wyoming St, Ste. 4140, Dayton, OH 45409 Phone: 937-208-4110 Fax: 937-208-6260 | |
Samantha Elizabeth Houser, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5701 Far Hills Ave, Dayton, OH 45429 Phone: 937-435-6222 | |
Sheela M Barhan, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Wyoming St, Suite 4130, Dayton, OH 45409 Phone: 937-208-6810 | |
Dr. Geoffrey David Towers, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Wyoming St, Suite 4130, Dayton, OH 45409 Phone: 937-208-6810 Fax: 937-222-7255 | |
Dr. Andre Todd Harris Sr., M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Elizabeth Pl, 5th Flr, Ste. M, Dayton, OH 45417 Phone: 937-228-4942 |